Search

everythinglearnresearchcommunity

for

Search:↓

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Androgens increase norepinephrine release, promoting smooth muscle growth in male sex organs, which may contribute to benign prostatic hypertrophy.

Steroid hormones are crucial for body functions and have various medical uses, but their misuse can lead to dependence.

Blocking androgen receptors boosts macrophages' ability to clear certain bacteria.

Low-dose DMSO may help treat castration-resistant prostate cancer by reducing key cancer cell receptors.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Male hormones can decrease the ability of immune cells to fight bacteria.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Gut bacteria can lower androgen levels in male mice.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Green tea extract and cycling hormone treatments may help treat advanced prostate cancer.

Isotretinoin shrinks sebaceous glands without affecting hair or skin color, unlike etretinate.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.

A new compound that could treat various androgen-related conditions was created and analyzed.

Garden cress extract may help treat skin inflammation and androgen-related disorders.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

Testosterone protects female heart cells from stress by activating estrogen receptors.

Natural products may help treat skin inflammation from abnormal adrenal hormones.

High levels of male hormones in women with PCOS can lead to fertility issues and symptoms like irregular periods, hair growth, acne, and hair loss; lifestyle changes are recommended for management.

Common baldness is a hereditary condition that can be treated with medications or surgery to prevent progression and improve self-esteem.